- Home
- Publications
- Publication Search
- Publication Details
Title
The role of polycomb repressive complexes in biliary tract cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 19, Issue 3, Pages 363-375
Publisher
Informa Healthcare
Online
2014-11-26
DOI
10.1517/14728222.2014.986460
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunostaining for Polycomb Group Protein EZH2 and Senescent Marker p16INK4a May Be Useful to Differentiate Cholangiolocellular Carcinoma From Ductular Reaction and Bile Duct Adenoma
- (2014) Motoko Sasaki et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Targeting histone methyltransferase EZH2 as cancer treatment
- (2014) Y. Kondo JOURNAL OF BIOCHEMISTRY
- Cholangiocarcinoma
- (2014) Nataliya Razumilava et al. LANCET
- Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer
- (2014) Tobias Kiesslich et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
- (2014) S. K. Knutson et al. MOLECULAR CANCER THERAPEUTICS
- L07.04 * PRECLINICAL CHARACTERIZATION OF E7438, A POTENT, SELECTIVE EZH2 INHIBITOR WITH ROBUST ANTITUMOR ACTIVITY AGAINST EZH2 MUTATED NHL XENOGRAFTS IN MICE
- (2013) H. Keilhack ANNALS OF ONCOLOGY
- Enhancer of Zeste Homolog 2 (EZH2) Promotes Progression of Cholangiocarcinoma Cells by Regulating Cell Cycle and Apoptosis
- (2013) Shigeki Nakagawa et al. ANNALS OF SURGICAL ONCOLOGY
- Aberrant DNA Methylation at Genes Associated with a Stem Cell-like Phenotype in Cholangiocarcinoma Tumors
- (2013) R. Sriraksa et al. Cancer Prevention Research
- Roles of histone methyl-modifying enzymes in development and progression of cancer
- (2013) Takeshi Suzuki et al. CANCER SCIENCE
- Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
- (2013) Sumera Rizvi et al. GASTROENTEROLOGY
- Self-renewal as a therapeutic target in human colorectal cancer
- (2013) Antonija Kreso et al. NATURE MEDICINE
- Bmi1 Enhances Tumorigenicity and Cancer Stem Cell Function in Pancreatic Adenocarcinoma
- (2013) Erica Proctor et al. PLoS One
- Noncoding RNA and Polycomb recruitment
- (2013) N. Brockdorff RNA
- Brief Report: The lincRNA Hotair Is Required for Epithelial-to-Mesenchymal Transition and Stemness Maintenance of Cancer Cell Lines
- (2013) Cleidson Pádua Alves et al. STEM CELLS
- Update of research on the role of EZH2 in cancer progression
- (2013) Liang Shen et al. OncoTargets and Therapy
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
- (2012) Francesco Crea et al. CANCER AND METASTASIS REVIEWS
- Polycomb in Stem Cells: PRC1 Branches Out
- (2012) Nuno Miguel Luis et al. Cell Stem Cell
- Dysregulation of the Repressive H3K27 Trimethylation Mark in Head and Neck Squamous Cell Carcinoma Contributes to Dysregulated Squamous Differentiation
- (2012) O. M. Gannon et al. CLINICAL CANCER RESEARCH
- TP53 Genomic Status Regulates Sensitivity of Gastric Cancer Cells to the Histone Methylation Inhibitor 3-Deazaneplanocin A (DZNep)
- (2012) L. L. Cheng et al. CLINICAL CANCER RESEARCH
- Current Status of Therapeutic Targeting of Developmental Signalling Pathways in Oncology
- (2012) Tobias Kiesslich et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives
- (2012) Federico Andreoli et al. CURRENT PHARMACEUTICAL DESIGN
- PRC2 during vertebrate organogenesis: A complex in transition
- (2012) Issam Aldiri et al. DEVELOPMENTAL BIOLOGY
- Advances in targeting the Hedgehog signaling pathway in cancer therapy
- (2012) Tobias Kiesslich et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Novel therapeutic Strategies for Targeting Liver Cancer Stem Cells
- (2012) Naoki Oishi et al. International Journal of Biological Sciences
- EZH2 Methyltransferase and H3K27 Methylation in Breast Cancer
- (2012) Kyung Hyun Yoo et al. International Journal of Biological Sciences
- Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells
- (2012) Yannick D. Benoit et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The developing cancer stem-cell model: clinical challenges and opportunities
- (2012) Louis Vermeulen et al. LANCET ONCOLOGY
- Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells
- (2012) Junko Kikuchi et al. LUNG CANCER
- PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family Complexes
- (2012) Zhonghua Gao et al. MOLECULAR CELL
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Stopping a chromatin enzyme
- (2012) Jeffrey A Simon Nature Chemical Biology
- Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells
- (2012) Irina Alimova et al. NEURO-ONCOLOGY
- Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation
- (2012) W. Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of BMI1, a Stem Cell Factor, in Cancer Recurrence and Chemoresistance: Preclinical and Clinical Evidences
- (2012) Hifzur Rahman Siddique et al. STEM CELLS
- The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
- (2011) J. Zhou et al. BLOOD
- The role of EZH2 in tumour progression
- (2011) C-J Chang et al. BRITISH JOURNAL OF CANCER
- Long Noncoding RNA, Polycomb, and the Ghosts Haunting INK4b-ARF-INK4a Expression
- (2011) F. Aguilo et al. CANCER RESEARCH
- (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells
- (2011) S. R. Choudhury et al. CARCINOGENESIS
- Aberrations of EZH2 in Cancer
- (2011) A. Chase et al. CLINICAL CANCER RESEARCH
- 3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells
- (2011) Tetsuhiro Chiba et al. INTERNATIONAL JOURNAL OF CANCER
- BMI1 as a novel target for drug discovery in cancer
- (2011) Liangxian Cao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Interaction Proteomics Analysis of Polycomb Proteins Defines Distinct PRC1 Complexes in Mammalian Cells
- (2011) Julien Vandamme et al. MOLECULAR & CELLULAR PROTEOMICS
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Cholangiocarcinoma—controversies and challenges
- (2011) Tushar Patel Nature Reviews Gastroenterology & Hepatology
- Overexpression of EZH2 and loss of expression of PTEN is associated with invasion, metastasis, and poor progression of gallbladder adenocarcinoma
- (2011) Dong-Cai Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- Roles of the Polycomb group proteins in stem cells and cancer
- (2011) H Richly et al. Cell Death & Disease
- S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition
- (2010) Annette Hayden et al. BREAST CANCER RESEARCH AND TREATMENT
- Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer
- (2010) Martin Sauvageau et al. Cell Stem Cell
- Cholangiocarcinoma: New Insights into Disease Pathogenesis and Biology
- (2010) Chiara Braconi et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Epigenetic regulation of signaling pathways in cancer: Role of the histone methyltransferase EZH2
- (2010) Daisy PF Tsang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a
- (2010) Kyoko L. Yap et al. MOLECULAR CELL
- Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
- (2010) Rajnish A. Gupta et al. NATURE
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polycomb Target Genes Are Silenced in Multiple Myeloma
- (2010) Antonia Kalushkova et al. PLoS One
- Polycomb group protein-mediated repression of transcription
- (2010) Lluís Morey et al. TRENDS IN BIOCHEMICAL SCIENCES
- Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
- (2009) W. Fiskus et al. BLOOD
- Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma
- (2009) Junpei Yamaguchi et al. CANCER SCIENCE
- Polycomb group protein Bmi1 is overexpressed and essential in anchorage-independent colony formation, cell proliferation and repression of cellular senescence in cholangiocarcinoma
- (2009) Motoko Sasaki et al. HUMAN PATHOLOGY
- Role of polycomb proteins Ring1A and Ring1Bin the epigenetic regulation of gene expression
- (2009) Miguel Vidal INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells
- (2009) Li-Bing Song et al. JOURNAL OF CLINICAL INVESTIGATION
- BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal
- (2009) M. Abdouh et al. JOURNAL OF NEUROSCIENCE
- The epigenetic regulators Bmi1 and Ring1B are differentially regulated in pancreatitis and pancreatic ductal adenocarcinoma
- (2009) Carles Martínez-Romero et al. JOURNAL OF PATHOLOGY
- Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin
- (2009) Junpei Yamaguchi et al. LABORATORY INVESTIGATION
- DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
- (2009) T. B. Miranda et al. MOLECULAR CANCER THERAPEUTICS
- Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression
- (2009) Ahmad M. Khalil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidemiology of biliary tract cancers: an update
- (2008) G. Randi et al. ANNALS OF ONCOLOGY
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study
- (2008) Katerina Vrzalikova et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Over-expression of polycomb group protein EZH2 relates to decreased expression of p16INK4a in cholangiocarcinogenesis in hepatolithiasis
- (2008) M Sasaki et al. JOURNAL OF PATHOLOGY
- The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma
- (2008) Motoko Sasaki et al. LABORATORY INVESTIGATION
- The cancer stem cell hypothesis: in search of definitions, markers and relevance
- (2008) Michail Shipitsin et al. LABORATORY INVESTIGATION
- Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
- (2008) Raphael Margueron et al. MOLECULAR CELL
- Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
- (2008) Yutaka Kondo et al. NATURE GENETICS
- Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours
- (2008) V. Häyry et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Bmi-1 expression predicts prognosis for patients with gastric carcinoma
- (2007) Jian-Hua Liu et al. JOURNAL OF SURGICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation